The invention provides 2-carboxamide piperazine compounds of formula I, R.sup.3.IN\'N.about.'R.sup.2I(0)z-oR.sup.4I wherein R', R.sup.2, R.sup.3 and R.sup.4 are as defined in the claims and methods of treatment and pharmaceutical compositions that utilize or comprise one or more such compounds. Compounds of the invention are useful for the treatment of mammalian infertility.
Claims What is claimed is: 1. A compound according to Formula I: ##STR00037## wherein R.sup.1 is H; R.sup.2 is selected from aryl, heteroaryl, 3-8-membered cycloalkyl and heterocycloalkyl; R.sup.3 is selected from C.sub.1-C.sub.16-alkyl, C.sub.2-C.sub.16-alkenyl, C.sub.2-C.sub.16-alkynyl, monocyclic aryl, monocyclic heteroaryl, 3-8-membered monocyclic cycloalkyl, monocyclic heterocycloalkyl, acyl, C.sub.1-C.sub.16-alkyl aryl, C.sub.1-C.sub.16-alkyl heteroaryl, C.sub.2-C.sub.16-alkenyl aryl, C.sub.2-C.sub.16-alkenyl heteroaryl, C.sub.2-C.sub.16-alkynyl aryl, C.sub.2-C.sub.16-alkynyl heteroaryl, C.sub.1-C.sub.16-alkyl cycloalkyl, C.sub.1-C.sub.16-alkyl heterocycloalkyl, C.sub.2-C.sub.16-alkenyl cycloalkyl, C.sub.2-C.sub.16-alkenyl heterocycloalkyl, C.sub.2-C.sub.16-alkynyl cycloalkyl, C.sub.2-C.sub.16-alkynyl heterocycloalkyl, alkoxycarbonyl, aminocarbonyl, C.sub.1-C.sub.16-alkyl carboxy, C.sub.1-C.sub.16-alkyl acyl, aryl acyl, heteroaryl acyl, C.sub.3-C.sub.8-(hetero)cycloalkyl acyl, C.sub.1-C.sub.16-alkyl acyloxy, C.sub.1-C.sub.16-alkyl alkoxy, C.sub.1-C.sub.16-alkyl alkoxycarbonyl, aminocarbonyl, C.sub.1-C.sub.16-alkyl acylamino, acylamino, C.sub.1-C.sub.16-alkyl sulfinyl, C.sub.1-C.sub.16-alkyl sulfanyl, C.sub.1-C.sub.16-alkyl ureido, C.sub.1-C.sub.16-alkyl carbamate, C.sub.1-C.sub.16-alkyl amino, C.sub.1-C.sub.16-alkyl ammonium; R.sup.4 is selected from C.sub.1-C.sub.12-alkyl, C.sub.2-C.sub.12-alkenyl, C.sub.2-C.sub.12-alkynyl, aryl, heteroaryl, 3-8-membered cycloalkyl, heterocycloalkyl, and amino; and pharmaceutically acceptable salts thereof. 2. The compound of claim 1 wherein R.sup.2 is aryl or heteroaryl. 3. The compound of claim 1, wherein R.sup.4 is selected from C.sub.1-alkyl, amino, aryl, heteroaryl, 3-8-membered cycloalkyl and heterocycloalkyl. 4. The compound of claim 1, wherein R.sup.2 is aryl; R.sup.3 is selected from C.sub.1-C.sub.8-alkyl, C.sub.1-C.sub.8-acyl amino and C.sub.1-C.sub.8-alkyl acyl and R.sup.4 is selected from C.sub.1-C.sub.6-alkyl, amino, aryl and heteroaryl. 5. The compound of claim 1, wherein R.sup.2 is fused phenyl. 6. The compound of claim 1, wherein R.sup.4 is thienyl. 7. The compound of claim 1 having the following Formula II: ##STR00038## wherein R.sup.5 is independently halogen or hydroxy; m is an integer of from 0 to 3; and pharmaceutically acceptable salts thereof. 8. The compound of claim 1 wherein R.sup.2 comprises a carbazolyl, tetrahydro-beta-carbolinyl or a benzimidazolyl moiety. 9. The compound of claim 1 that is selected from the following group: 4-hexyl-1-(thiophene-2-sulfonyl)-piperazine-2-carboxylic acid (1-ethyl-2-pyridinyl-3-yl-1H-benzoimidazol-5-yl)-amide); 4-(thiophene-2-sulfonyl)-piperazine-1,3-dicarboxylic acid 3-[(9-ethyl-9H-carbazol-3-yl)amide]-1-pentylamide; 4-(thiophene-2-sulfonyl)-piperazine-1,3-dicarboxylic acid 1-ethylamide 3-[(9-ethyl-9H-carbazol-3-yl)amide]; 4-pentanoyl-1-(thiophene-2-sulfonyl)-piperazine-2-carboxylic acid (9-ethyl-9H-carbazol-3-yl)amide; 4-hexyl-1-(thiophene-2-sulfonyl)-piperazine-2-carboxylic acid (9-ethyl-9H-carbazol-3-yl)amide; 4-dimethylsulfamoyl-piperazine-1,3-dicarboxylic acid 3-[(9-ethyl-9H-carbazol-3-yl)amide] 1-pentylamide; 4-(1-methyl-1H-imidazole-4-sulfonyl)-piperazine-1,3-dicarboxylic acid 3-[(9-ethyl-9H-carbazol-3-yl)-amide] 1-pentylamide; 4-(thiophene-2-sulfonyl)-piperazine-1,3-dicarboxyclic acid 1-pentylamide 3-[(3-pyridin-4-yl-phenyl)-amide]; 4-hexyl-1-(thiophene-2-sulfonyl)-piperazine-2-carboxylic acid (1-oxo-2,3,4,9-tetrahydro-1H-beta-carbolin-6-yl)-amide; 4-heptyl-1-(thiophene-2-sulfonyl)-piperazine-2-carboxylic acid (1-ethyl-2-pyridin-3-yl-1H-benzoimidazol-5-yl)-amide; 4-pentyl-1-(thiophene-2-sulfonyl)-piperazine-2-carboxylic acid (1-oxo-2,3,4,9-tetrahydro-1H-beta-carbolin-6-yl)amide; 4-heptyl-1-(thiophene-2-sulfonyl)-piperazine-2-carboxylic acid (1-oxo-2,3,4,9-tetrahydro-1H-beta-carbolin-6-yl)amide; 4-(3-methylsulfanyl-propyl)-1-(thiophene-2-sulfonyl)-piperazine-2-carboxy- lic acid (9-ethyl-9H-carbazol-3-yl)-amide; 4-(4-ethyl-furan-3-ylmethyl)-1-(thiophene-2-sulfonyl)-piperazine-2-carbox- ylic acid (9-ethyl-9H-carbazol-3-yl)-amide; 3-(9-ethyl-9H-carbazol-3-ylcarbamoyl)-4-(thiophene-2-sulfonyl)-piperazin-- 1-yl]acetic acid ethyl ester; 1-benzenesulfonyl-4-hexyl-piperazine-2-carboxylic acid (1-ethyl-2-pyridin-3-yl-1H-benzoimidazol-5-yl)amide; 4-pentyl-1-thiophene-2-sulfonyl)-piperazine-2-carboxylic acid (1-ethyl-2-pyridin-3-yl-1H-benzoimidazol-5-yl)amide; 4-hexyl-1-thiophene-2-sulfonyl)-piperazine-2-carboxylic acid (1-ethyl-2-pyridin-3-yl-1H-benzoimidazol-5-yl)amide; 1-(4-fluoro-benzenesulfonyl)-4-hexyl-piperazine-2-carboxylic acid (1-ethyl-2-pyridin-3-yl-1H-benzoimidazol-5-yl)amide; 1-(2-fluoro-benzenesulfonyl)-4-hexyl-piperazine-2-carboxylic acid (1-ethyl-2-pyridin-3-yl-1H-benzoimidazol-5-yl)amide; 4-octyl-1-(thiophene-2-sulfonyl)-piperazine-2-carboxylic acid (1-ethyl-2-pyridin-4-yl-1H-benzoimidazol-5-yl)amide; 4-heptyl-1-(thiophene-2-sulfonyl)-piperazine-2-carboxylic acid (1-ethyl-2-pyridin-4-yl-1H-benzoimidazol-5-yl)amide; 1-dimethylsulfamoyl-4-hexyl-piperazine-2-carboxylic acid (1-ethyl-2-pyridin-3-yl-1H-benzoimidazol-5-yl)amide; 1-(butane-1-sulfonyl)-4-hexyl-piperazine-2-carboxylic acid (1-ethyl-2-pyridin-3-yl-1H-benzoimidazol-5-yl)amide; 4-hexyl-1-(thiophene-2-sulfonyl)-piperazine-2-carboxylic acid (1-ethyl-2-pyridin-4-yl-1H-benzoimidazol-5-yl)amide; 4-(3-methylsulfanyl-propyl)-1-(thiophene-2-sulfonyl)-piperazine-2-carboxy- lic acid (1-ethyl-2-pyridin-4-yl-1H-benzoimidazol-5-yl)amide; 4-octyl-1-(thiophene-2-sulfonyl)-piperazine-2-carboxylic acid (1-ethyl-2-pyridin-3-yl-1H-benzoimidazol-5-yl)amide; and pharmaceutically acceptable salts thereof. 10. A pharmaceutical composition comprising the compound of claim 9. 11. A pharmaceutical composition comprising a pharmaceutically acceptable carrier and one or more compounds of claim 9. 12. A pharmaceutical composition of claim 11 wherein the compound is packaged together with instructions for use of the compound to treat infertility. 13. The compound of claim 7 wherein m is an integer of from 0 to 2. 14. A method for treating infertility in a mammal, comprising administering to a mammal suspected of infertility a therapeutically effective amount of a compound of claim 1. 15. The method of claim 14, wherein R.sup.2 is aryl or heteroaryl. 16. The method of claim 14, wherein R.sup.4 is selected from C.sub.1-C.sub.6-alkyl, amino, aryl, heteroaryl, 3-8-membered cycloalkyl and heterocycloalkyl. 17. The method of treatment of claim 14, wherein R.sup.2 is aryl; R.sup.3 is selected from C.sub.1-C.sub.8-alkyl, C.sub.1-C.sub.8-acyl amino and C.sub.1-C.sub.8-alkyl acyl and R.sup.4 is selected from C.sub.1-C.sub.6-alkyl, amino, aryl and heteroaryl. 18. The method of claim 14 wherein the compound has the following Formula II: ##STR00039## wherein R.sup.5 is independently halogen or hydroxy; m is an integer of from 0 to 3; and pharmaceutically acceptable salts thereof. 19. The method of claim 14 wherein R.sup.2 comprises a carbazolyl, tetrahydro-beta-carbolinyl or benzimidazolyl moiety. 20. The method of claim 14 wherein the compound of formula I is selected from the following group: 4-hexyl-1-(thiophene-2-sulfonyl)-piperazine-2-carboxylic acid (1-ethyl-2-pyridinyl-3-yl-1H-benzoimidazol-5-yl)-amide); 4-(thiophene-2-sulfonyl)-piperazine-1,3-dicarboxylic acid 3-[(9-ethyl-9H-carbazol-3-yl)amide]-1-pentylamide; 4-(thiophene-2-sulfonyl)-piperazine-1,3-dicarboxylic acid 1-ethylamide 3-[(9-ethyl-9H-carbazol-3-yl)amide]; 4-pentanoyl-1-(thiophene-2-sulfonyl)-piperazine-2-carboxylic acid (9-ethyl-9H-carbazol-3-yl)amide; 4-hexyl-1-(thiophene-2-sulfonyl)-piperazine-2-carboxylic acid (9-ethyl-9H-carbazol-3-yl)amide; 4-dimethylsulfamoyl-piperazine-1,3-dicarboxylic acid 3-[(9-ethyl-9H-carbazol-3-yl)amide] 1-pentylamide; 4-(1-methyl-1H-imidazole-4-sulfonyl)-piperazine-1,3-dicarboxylic acid 3-[(9-ethyl-9H-carbazol-3-yl)-amide] 1-pentylamide; 4-(thiophene-2-sulfonyl)-piperazine-1,3-dicarboxyclic acid 1-pentylamide 3-[(3-pyridin-4-yl-phenyl)-amide]; 4-hexyl-1-(thiophene-2-sulfonyl)-piperazine-2-carboxylic acid (1-oxo-2,3,4,9-tetrahydro-1H-beta-carbolin-6-yl)-amide; 4-heptyl-1-(thiophene-2-sulfonyl)-piperazine-2-carboxylic acid (1-ethyl-2-pyridin-3-yl-1H-benzoimidazol-5-yl)-amide; 4-pentyl-1-(thiophene-2-sulfonyl)-piperazine-2-carboxylic acid (1-oxo-2,3,4,9-tetrahydro-1H-beta-carbolin-6-yl)amide; 4-heptyl-1-(thiophene-2-sulfonyl)-piperazine-2-carboxylic acid (1-oxo-2,3,4,9-tetrahydro-1H-beta-carbolin-6-yl)amide; 4-(3-methylsulfanyl-propyl)-1-(thiophene-2-sulfonyl)-piperazine-2-carboxy- lic acid (9-ethyl-9H-carbazol-3-yl)-amide; 4-(4-ethyl-furan-3-ylmethyl)-1-(thiophene-2-sulfonyl)-piperazine-2-carbox- ylic acid (9-ethyl-9H-carbazol-3-yl)-amide; 3-(9-ethyl-9H-carbazol-3-ylcarbamoyl)-4-(thiophene-2-sulfonyl)-piperazin-- 1-yl]acetic acid ethyl ester; 1-benzenesulfonyl-4-hexyl-piperazine-2-carboxylic acid (1-ethyl-2-pyridin-3-yl-1H-benzoimidazol-5-yl)amide; 4-pentyl-1-thiophene-2-sulfonyl)-piperazine-2-carboxylic acid (1-ethyl-2-pyridin-3-yl-1H-benzoimidazol-5-yl)amide; 4-hexyl-1-thiophene-2-sulfonyl)-piperazine-2-carboxylic acid (1-ethyl-2-pyridin-3-yl-1H-benzoimidazol-5-yl)amide; 1-(4-fluoro-benzenesulfonyl)-4-hexyl-piperazine-2-carboxylic acid (1-ethyl-2-pyridin-3-yl-1H-benzoimidazol-5-yl)amide; 1-(2-fluoro-benzenesulfonyl)-4-hexyl-piperazine-2-carboxylic acid (1-ethyl-2-pyridin-3-yl-1H-benzoimidazol-5-yl)amide; 4-octyl-1-(thiophene-2-sulfonyl)-piperazine-2-carboxylic acid (1-ethyl-2-pyridin-4-yl-1H-benzoimidazol-5-yl)amide; 4-heptyl-1-(thiophene-2-sulfonyl)-piperazine-2-carboxylic acid (1-ethyl-2-pyridin-4-yl-1H-benzoimidazol-5-yl)amide; 1-dimethylsulfamoyl-4-hexyl-piperazine-2-carboxylic acid (1-ethyl-2-pyridin-3-yl-1H-benzoimidazol-5-yl)amide; 1-(butane-1-sulfonyl)-4-hexyl-piperazine-2-carboxylic acid (1-ethyl-2-pyridin-3-yl-1H-benzoimidazol-5-yl)amide; 4-hexyl-1-(thiophene-2-sulfonyl)-piperazine-2-carboxylic acid (1-ethyl-2-pyridin-4-yl-1H-benzoimidazol-5-yl)amide; 4-(3-methylsulfanyl-propyl)-1-(thiophene-2-sulfonyl)-piperazine-2-carboxy- lic acid (1-ethyl-2-pyridin-4-yl-1H-benzoimidazol-5-yl)amide; 4-octyl-1-(thiophene-2-sulfonyl)-piperazine-2-carboxylic acid (1-ethyl-2-pyridin-3-yl-1H-benzoimidazol-5-yl)amide; and pharmaceutically acceptable salts thereof. 21. The method of claim 14 wherein the mammal is a human. 22. The method of claim 21 wherein the mammal is a female. 23. The method of claim 22 wherein the mammal is suffering from an ovulatory disorder. 24. The method of claim 22 wherein the mammal is being treated with an assisted reproduction procedure. 25. The method of claim 22 wherein the mammal is undergoing in-vitro fertilization. 26. The method of claim 21 wherein the mammal is a male. 27. The method of claim 22 wherein the mammal is a male suffering from a spermatogenesis disorder. 